SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to significant price movement and high trading volume, sparking discussions about a potential short squeeze. The community is actively debating entry points, profit-taking strategies, and whether the stock will continue its upward trajectory, drawing comparisons to other high-flying stocks. Some traders are pointing to the company's low float and recent focus on AI-powered robotics as potential catalysts for continued momentum.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation surrounding potential U.S. cannabis rescheduling following comments from President Trump, fueling community discussions about executive action and its potential impact. Traders are debating the likelihood and timing of any formal announcement, as well as the potential for a short squeeze. Community members are actively discussing the stock's price movement, potential catalysts, and trading strategies.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending due to concerns about slower growth, with community members pointing to recent CFO commentary at a conference and an analyst downgrade as potential drivers for price suppression. Despite this, some are optimistic about PayPal's fundamentals, aggressive buybacks, and strategic moves into areas like banking and stablecoins, viewing the negative sentiment as a contrarian buying opportunity. Community members are discussing the potential for a turnaround and the possibility of a short squeeze.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to positive interim data from its Phase 2b trial, showing promising results in brain metastases imaging, with the community actively discussing the potential for a short squeeze and anticipating further details from an upcoming webinar. The stock's high trading volume and significant pre-market gains are fueling speculative interest, despite some concerns about potential pullbacks and short attacks. This surge is also drawing attention to the broader oncology radiopharmaceutical sector.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Next, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Next segment is involved in the expenses and investments for emerging business initiatives aimed at creating value for Ford in vehicle-adjacent market segments. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is trending as investors digest a significant EV write-down and a strategic shift towards hybrid vehicles, which is being interpreted by some as a pragmatic move to focus on profitability and align with current market demand. The community is actively discussing the implications of this shift, with debates around whether it signals a retreat from EVs or a necessary adjustment in a challenging market landscape. Amidst the EV strategy recalibration, analysts are weighing in, setting price targets and evaluating Ford's potential to capitalize on policy shifts favoring domestic production.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is surging amid reports that an executive order to reclassify marijuana could be signed soon, potentially as early as this week. The community is buzzing about the implications of rescheduling for tax relief, research, and institutional investment, while also closely watching for official confirmation and potential market reactions. Some traders express caution due to past disappointments in the sector, while others see this as the start of a major upward trend.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending downwards, with the community citing overall negative sentiment towards AI as a key factor despite the company's prior deal with Microsoft. Some traders point to potential tax-loss harvesting and broader market concerns as contributing to the recent price action. Discussions also involve speculation about future catalysts and whether current levels represent a buying opportunity or further downside risk.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the stock makes new 2025 highs, with community members discussing its potential to reach $500 amidst debate on the company's valuation and Elon Musk's influence. Speculation around Tesla's autonomous driving advancements and the potential for a SpaceX IPO are also fueling the conversation, alongside concerns about the company's fundamentals.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending amid discussions about its AI strategy and a potential acquisition, sparking mixed community sentiment.  Some believe NOW is well-positioned to benefit from AI, while others express concerns about market share and valuation.  The stock's recent price decline and high trading volume are also driving conversation.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chun Sing Chan on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

CLIK is trending due to chatter around its low float and potential for a significant price surge, with some comparing it to other recent low-float runners. Discussions also involve the company's fundamentals, potential news catalysts, and high borrow rate, leading to speculation about a possible short squeeze. Some traders are moving profits from other stocks into CLIK, anticipating a substantial upward movement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vivo Capital LLC Has $5.42 Million Stock Position in Unicycive Therapeutics, Inc. $UNCY

Vivo Capital LLC lowered its position in shares of Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) by 90.0% in the second quarter, according to its most recent 13F filing with the Securities...

Unicycive Therapeutics (NASDAQ:UNCY) Trading Up 5.6% - Time to Buy?

Unicycive Therapeutics (NASDAQ:UNCY) Trading 5.6% Higher - Time to Buy...

UNCY FY2025 EPS Boosted by Brookline Capital Management

Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) - Research analysts at Brookline Capital Management boosted their FY2025 EPS estimates for Unicycive Therapeutics in a research report issued...

HC Wainwright Has Positive Outlook for UNCY FY2029 Earnings

Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) - Research analysts at HC Wainwright boosted their FY2029 EPS estimates for Unicycive Therapeutics in a research note issued to investors on...

Unicycive Therapeutics (NASDAQ:UNCY) Releases Quarterly Earnings Results, Beats Expectations By $0.29 EPS

Unicycive Therapeutics (NASDAQ:UNCY - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.33) earnings per share for the quarter, beating the consensus...

UNCY Deadline Today: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) between March...

Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - UNCY

Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - UNCY Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the...

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Unicycive Therapeutics, Inc. (Unicycive or the Company) (NASDAQ: UNCY) and reminds investors of...

UNCY LAWSUIT ALERT: Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

UNCY LAWSUIT ALERT: Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline UNCY LAWSUIT ALERT: Levi & Korsinsky Notifies Unicycive...

Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Seeking Recovery for Investors - Contact The Gross Law Firm

Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Seeking Recovery for Investors - Contact The Gross Law Firm Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Seeking...

Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.

Current Price	$5.88
Prev Close	$6.23
Open	$6.31
Dividend Yield	0.00%
50-Day Moving Average	$5.27
Beta	0.73
Avg. Volume	453,356.11
PE Ratio	-1.92

52-Week High	$11.00
52-Week Low	$3.71
Market Capitalization	$133.89M
EPS (Annual)	-$5.65
Price to Book	3.47
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

UNCY
Unicycive Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Latest UNCY News

UNCYUnicycive Therapeutics Inc